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ABSTRACT 29 
Background and aims: Glomerular hyperfiltration (GH) is proposed as one of the earliest events in 30 
obesity (OB)-associated renal disease. Children with GH and type-1 diabetes showed increased 31 
chemokine levels. Chemokine associations with glomerular filtration rate (GFR) and metabolic 32 
features in prepubertal children with overweight (OW)/OB are unknown. Methods and results: Cross-33 
sectional study. 75 prepubertal children (aged: 9.0 ± 1.7 years) with OW/OB were studied. Clinical 34 
and metabolic characteristics (including non-esterified fatty acids, NEFA) and GFR (combined 35 
Zappitelli equation) were assessed. GH was defined as GFR >135 ml/min.1.73 m2. Serum levels of 36 
regulated on activation, normal T cell expressed and secreted (RANTES)/CCL5, interleukin-8 (IL-37 
8)/CXCL8 and monokine-induced by interferon-g (MIG)/CXCL9 were measured by ELISA. Age- 38 
and sex-adjusted correlations and differences were tested. 48% of the cohort was female and 13% 39 
were OW, 54% OB and 33% severe OB. Prepubertal children with GH showed lower z-BMI (-12%), 40 
NEFA (-26%) and uric acid (-22%) than those without GH (all p < 0.05). Similarly to high sensitivity 41 
C-reactive protein (hsCRP), there were no differences in serum chemokines between children with 42 
GH or not (all p > 0.05). Adjusted correlations were significant for RANTES and z-BMI (r Z 0.26; p 43 
< 0.05) and for MIG with z-BMI (r Z -0.26; p < 0.05) and with NEFA (r Z 0.27; p < 0.05). Conclusion: 44 
GH was not associated with higher chemokine levels in prepubertal children with OW/OB. Decreased 45 
rather than elevated GFR values were correlated with obesity and worse metabolic profiles. 46 
Chemokines levels in children with severe OB suggest a regulation of the immune response. Follow-47 
up studies are needed to address the clinical implications of these findings. 48 
Introduction 49 
Childhood obesity (OB) is a growing health problem worldwide [1]. Children with overweight (OW) 50 
and/or OB are at increased risk for developing several comorbidities during adult age such as type 2 51 
diabetes and renal and cardiovascular diseases, among others [2,3]. In the development of obesity-52 
associated renal disease an early stage of elevated glomerular filtration rate (GFR) or glomerular 53 
hyperfiltration (GH) is proposed [4]. Whether elevated GFR is a relevant clinical sign indicating early 54 
impairment in renal function in children with OB is a matter of debate [5e9]. Some reports described 55 
increased GFR in children with OB in comparison with normal-weight children; however, others 56 
showed decreased GFR levels [5e9]. In part, controversy arises from the difficulties associated with 57 
the definition of GH. Some authors used an estimated GFR calculated by the modified Schwartz 58 
equation, which uses only serum creatinine concentration, while others used equations with cystatin 59 
C concentration alone or with a combination of both creatinine and cystatin C levels [5,7,8]. Also, 60 
different authors employed different cut off points of GFR, although a value >135 ml/min.1.73 m2 is 61 
frequently used in the literature [5,10]. In adults with OB and obesity related glomerulopathy (ORG), 62 
GH is commonly associated with metabolic alterations and increased inflammatory markers [4]. 63 
Whether such associations are also found in prepubertal children with OB have not been fully 64 
described. Lee et al. [11] showed increased triglycerides and markers of insulin resistance in 65 
adolescents with GH. In addition, Di Bonito et al. [12] showed that OB children (6e16 years) with an 66 
altered GFR (defined as >80th percentile or <20th percentile) were at increased risk of presenting 67 
elevated blood pressure (BP), impaired fasting glucose (IFG) and elevated white blood cell counts. 68 
Non-esterified fatty acids (NEFA) are at the hallmark of metabolic abnormalities and endothelial 69 
dysfunction in adults with OB and insulin resistance [13]. Impaired lipolysis and elevated NEFA in 70 
adults with OB were linked to ectopic fat deposition in several organs, including the kidneys [14]. 71 
“Fatty” kidney could be one possible explanation to the impairment of renal function in OB [14]. 72 
Indeed, a recent study showed that single nucleotide polymorphisms (SNPs) predisposing to ectopic 73 
fat accumulation were associated with lower GFR values in OB children with non-alcoholic fatty 74 
liver disease [15]. NEFA levels and its association with GFR and inflammatory markers in 75 
prepubertal children has been scarcely studied. A link between inflammatory markers and GH was 76 
suggested by a positive correlation between GFR and myeloperoxidase activity in a Portuguese cohort 77 
of prepubertal children with OW/OB [16]. However, most of the studies regarding GH and 78 
chemokines were carried out in children and adolescents with type 1 diabetes. In particular, children 79 
with type 1 diabetes and GH showed elevated urinary excretion of monocyte chemoattractant protein 80 
(MCP)-1, regulated on activation, normal T cell expressed and secreted (RANTES) and eotaxin in 81 
comparison with those without GH [17]. T lymphocyte chemokines, like RANTES/CCL5 and 82 
interleukin-8 (IL-8)/ CXCL8, are secreted by adipose tissue and are proposed as important mediators 83 
in the cross-talk between OB and cardiovascular disease [18e20]. Another chemokine relevant to 84 
vascular health is the monokine induced by interferon- g (MIG)/CXCL9 which is postulated as an 85 
important mediator in hypertension and cardiovascular disease [21]. In children with OB, levels of 86 
RANTES, IL-8 and MIG decreased with body weight reductions or BP changes during intervention 87 
studies [22,23]. Then, these chemokines may be involved in early changes of the GFR in prepubertal 88 
children with OB. The aim of the present study was to characterize the correlations of serum 89 
chemokines with GFR and metabolic alterations in a cohort of prepubertal children with OW/ OB. A 90 
secondary analysis was performed to explore differences between children with or without severe 91 
OB. 92 
Methods 93 
Sample size, study design and population 94 
Sample size was calculated in the base of a previous study on correlations between chemokines and 95 
GFR in children and adolescents [17]. As it was done in pediatric patients with type 1 diabetes, a-96 
priori we multiplied the result by 1.5 for final sample size estimation. The number of patients to be 97 
studied with an effect size of 0.381, 80% power and two-tailed significance level of 0.05, multiplied 98 
by 1.5 was 73. The studied cohortwas part from an ongoing prospective study which consecutively 99 
recruited every child between 5 and 17 years with OWor OB who consulted to the Pediatric Diabetes 100 
and Nutrition Service of the Complejo Médico Churruca Visca, Buenos Aires, Argentina, during 101 
April 2017 to October 2018. Out of the 183 patients recruited, we filtered the prepubertal ones 102 
(nZ109). Fromthese, a simple random sample of 80 patients was used for the analysis. At the time of 103 
measuring high sensitivity C reactive protein (hsCRP), 5 patients had to be excluded in the basis of a 104 
value >10 mg/l. Thefinal numberof prepubertal children included in this cross-sectional study was 105 
75. All patients, including the group of normal weight children, and their parents or responsible adult 106 
signed the assent and consent forms, respectively, before participation in the study. The protocol was 107 
approved by the Ethics Committee of the Complejo Médico Churruca-Visca. The general exclusion 108 
criteria for the study were diabetes, hypothyroidism or treatment with levothyroxine, concomitant 109 
autoimmune or liver pathologies, an urinary albumin-creatinine ratio >30 mg/g, clinical signs of an 110 
infectious disease or a hsCRP >10 mg/l. 111 
Clinical and laboratory measurements 112 
All the patients underwent a clinical interview in the presence of their parents or responsible adult in 113 
which height and weight were determined without shoes and wearing light clothes. Body mass index 114 
(BMI) was calculated and BMI classification was performed according to the z-score from the World 115 
Health Organization (WHO) [24]. Severe OB was defined by a z-BMI > þ3.0. BP was measured 116 
twice after a 5 min rest in the sitting position and the average of both measurements was recorded. 117 
The American Academy of Pediatrics (AAP) 2017 guidelines were used to calculate BP z-scores and 118 
to define elevated BP [25]. Waist circumference (WC) was measured at the mid-point between the 119 
iliac crest and the 10th rib and elevated WC classified as >90th percentile of the Bogalusa Heart 120 
Study [26]. After a 12 h overnight fast, blood samples were drawn and general lab measurements 121 
were carried out within a 24 h period. Serum samples we  re frozen at 70 C for the hsCRP and 122 
chemokines measurements. General laboratory testswere carried out in aUnicel DxC 800 (Beckman 123 
Coulter, USA) autoanalyzer by standardized methods. Cystatin C concentrationwas measured with 124 
an immunoturbidimetric assay (Diazyme, USA) and NEFA by a colorimetric assay (Randox, UK) 125 
according to manufacturer indications. HsCRP was measured by a nephelometric assay (Immage, 126 
Beckman Coulter, USA). GFR was estimated by the combined creatinine and cystatin C Zappitelli 127 
formula andGHwas defined in presence of a GFR >135 ml/min.1.73 m2 [27]. In order to verify the 128 
GH cut-off suggested by bibliography [28,29], 26 samples of prepubertal normal weight children 129 
were tested for creatinine and cystatin C and only one patient showed an GFR outside the defined 130 
reference range (90e135 ml/ min.1.73 m2). These 26 children (44% female, aged: 9  2 years) were 131 
attended in the same Hospital service as the patients and, besides being normal-weight [z-BMI: 132 
median (Q1dQ3), 0.07 (-0.67 d0.62)] met the same exclusion criteria as the patients with OW/OB. 133 
The range of GFR from these children was between 98 and 136 ml/min.1.73 m2, with a median at 134 
117 ml/min.1.73 m2 and Q1dQ3 Z 111e126 ml/min.1.73 m2. Serum levels of RANTES/CCL5, 135 
MIG/CXCL9 and IL-8/ CXCL8 were measured by ELISA (R&D systems, USA). Cardiometabolic 136 
risk factors were categorized according to the definition of metabolic syndrome of Cook et al. [30] 137 
modified by the Sociedad Argentina de Pediatría. The following cut-offs were used: abdominal OB, 138 
WC > 90th percentile; elevated BP, systolic or diastolic BP > 90th percentile; impaired fasting 139 
glucose (IFG), glucose > 100 mg/dl; hypertriglyceridemia (HTG), TG > 110 mg/dl and low HDL-C, 140 
HDL-C < 40 mg/dl. 141 
Statistical analyses 142 
Variables were tested for normality by the ShapiroeWilks test. Normally distributed variables are 143 
shown as mean ± standard deviation (sd) and skewed distributed variables as median (Q1eQ3). 144 
According to data distribution, Pearson or Spearman correlation tests were used. The different groups 145 
were compared by Student T test or ManneWhitney U test for normally or skewed distributed 146 
variables, respectively. Following log-transformation of skewed variables partial correlation test or 147 
ANCOVA was used to adjust by age and sex. Residuals of multivariate tests were checked for 148 
normality to evaluate the models. Categorical variables were compared with the Fisher Exact test. 149 
SPSS 25.0 (IBM, USA) was used for statistical analyses. Tests were considered statistically 150 
significant with a significance value (p) < 0.05. 151 
Results 152 
Population characteristics and evaluation of renal function 153 
The studied population comprised 75 prepubertal children (48% female) of which 13% showed OW, 154 
54% OB and 33% severe OB. The overall prevalence of metabolic syndrome components were: 155 
abdominal OB: 73%, low HDL-C: 57%, HTG: 39%, elevated BP: 23%, and IFG: 9%. Metabolic 156 
syndrome was diagnosed in 32% of the children and GH was found in 16%. Clinical and laboratory 157 
characteristics according to the presence of GH are shown in Table 1. Prepubertal children with GH 158 
showed lower z-BMI, NEFA and uric acid than those with normal GFR. GFR correlated with age (r 159 
Z -0.32; p Z 0.005), NEFA (r Z -0.30; p Z 0.011) and uric acid levels (r Z -0.29; p Z 0.011). These 160 
correlation were independent of sex and age and sex, accordingly. Besides its inverse correlation with 161 
GFR, uric acid levels correlated with the number of cardiometabolic risk factors (r Z 0.37; p < 0.001), 162 
LDL-C (r Z 0.30; p Z 0.010), TG/ HDL-C (r Z 0.28; p Z 0.015), NEFA (r Z 0.39; p < 0.001) and 163 
hsCRP (r Z 0.29; p Z 0.014). These correlations, except that with TG/HDL-C, remained statistically 164 
significant when adjusting by age and sex. 165 
Serum chemokine levels and its correlation with renal function and metabolic characteristics 166 
Similarly to the inflammatory marker hsCRP (Table 1), there were no differences in serum 167 
chemokines between children with GH or not [RANTES: 27.2 (22.4e29.0) vs. 26.9 (23.6e30.0) 168 
ng/ml; MIG: 420 (329e523) vs. 454 (276e686) pg/ml; and IL-8: 551 (311e782) vs. 630 (406e922) 169 
pg/ml, respectively, all p > 0.05]. MIG and IL-8 were both inversely correlated with GFR (r Z -0.27, 170 
p Z 0.035; and r Z -0.25, p Z 0.022, respectively). These correlations were no longer significant when 171 
tests were adjusted by age and sex (p > 0.05). RANTES levels were not correlated with GFR (p > 172 
0.05). Correlations of serum chemokine levels with z-BMI and NEFA are shown in Fig. 1. Strikingly, 173 
while RANTES was directly correlated with z-BMI, MIG was inversely correlated with z-BMI and 174 
positively with NEFA (Fig. 1). IL-8 levels were closely correlated with MIG levels (r Z 0.78; p < 175 
0.001), and IL-8 correlations with z-BMI and NEFA mirrored those of MIG (Fig. 1). In analyses 176 
adjusted by age and sex, only RANTES correlation with z-BMI and both MIG correlations remained 177 
statistically significant (all p < 0.05). None of the other metabolic characteristics were correlated with 178 
the serum chemokine levels. HsCRP levels were significantly correlated with z-BMI (r Z 0.45; p < 179 
0.001) and this correlation remained significant even when adjusting by age and sex (p < 0.05). 180 
Subgroup analysis according to severe obesity 181 
Prepubertal children with severe OB were younger and showed a worse cardiometabolic profile 182 
(Table 2). Strikingly, children with severe OB did not present GH which was exclusively seen in 183 
children without severe OB (Table 1). Children with severe OB presented higher levels of hsCRP but 184 
lower levels of the chemokines IL-8 and MIG. Differences in hsCRP and MIG remained statistically 185 
significant in models adjusted by age and sex (Table 2). Adjusted differences were also significant 186 
for HOMA-IR and TG. 187 
Discussion 188 
The present study shows that serum chemokines concentrations were not different between 189 
prepubertal children with or without GH. Moreover, children with GH were less obese and did not 190 
showed higher levels of cardiometabolic risk factors. In fact, children with severe OB did not show 191 
a higher GFR, in spite of being younger. Altogether, these results suggest the existence of a pool of 192 
OB children with an early decline of GFR in which GH could have happened at even younger ages, 193 
as declining GFR values in childhood OB were also noticed by others [9,15]. As an alternative, the 194 
present definition of GH (GFR > 135 ml/min.1.73 m2) might be limited to detect early renal 195 
impairment. Whatever the case, this insight is clinically relevant as prepubertal children with OW/OB 196 
developing early alterations in renal function would not be identified by current biochemical markers. 197 
In this cohort of prepubertal children there were no correlations between GFR and z-BMI. Moreover, 198 
instead of positive, negative correlations of GFR with NEFA and uric acid were seen. Both elevated 199 
NEFA and uric acid are not only markers but also proposed mediators of cardiometabolic 200 
derangements in OB. Uric acid was positively correlated with cardiometabolic risk factors, the 201 
TG/HDL-C ratio, LDL-C, NEFA and hsCRP, similarly to what it was reported by other studies in 202 
prepubertal children with OB [31]. Thus, our data supports the notion that OB and its metabolic 203 
alterations could lead to a reduction of GFR rather than to an increase in prepubertal children. This 204 
result contrasts with the studies that used different GFR equations, like Bouvet or modified Schwartz 205 
[5,9,27]. In particular, Bouvet equation includes weight as a variable and then higher but not lower 206 
GFR values in OB children could be expected [5]. On the other hand, the use of Schwartz equation 207 
could lead to bias related to body distribution of fat and lean mass and its influence on creatinine 208 
levels [9]. Although other sources of variation in serum cystatin C levels, like increased secretion by 209 
adipose tissue cannot be dismissed [32], our results support those of a Portuguese cohort of 313 210 
prepubertal children (48% with OW/OB) [7]. In the latter, not only GFR using Zappitelli equation 211 
was negatively correlated with z-BMI, but also 24h creatinine clearance [7]. Nonetheless, the impact 212 
of OB over GFR in childhood remains to be determined in longitudinal studies. Prepubertal children 213 
with severe OB showed a worse cardiometabolic profile and, paradoxically, elevated hsCRP and 214 
decreased MIG levels. In this point, it should be noticed that while hsCRP were positively correlated 215 
with z-BMI, MIG did in an opposite way. Then, the IL-1b d IL-6 d CRP axis could reflect the 216 
developing inflammatory state set up by the onset and progression of fat accumulation, as it was also 217 
noticed in cross-sectional and intervention studies involving prepubertal children [33e36]. On the 218 
other hand, the inverse correlation between z-BMI and MIG could be related to an adaptative 219 
counterregulation involving the adipose tissue regulatory T cells (Treg) [37]. This adaptative Treg 220 
response was increased in OB vs. lean humans and was more relevant in subcutaneous than visceral 221 
adipose tissue [38,39]. Such specific responses in fat depots is relevant to the interpretation of data 222 
on prepubertal children with OB. Before puberty, gain of subcutaneous fat mass is more relevant, 223 
while from puberty onset and onward visceral fat accumulation is more significant [40,41]. Indeed, 224 
when comparing prepubertal children with or without OB differences in subcutaneous adipose tissue 225 
were quantitatively more significant than those in visceral adipose tissue [36,42]. Also, subcutaneous 226 
rather than visceral adipose tissue was correlated with reduced insulin sensitivity and ectopic fat 227 
accumulation before puberty [36,42,43]. On the other hand, MIG negative correlation with NEFA 228 
could be at some point attributed to the known effects of IFN-g on lipolysis [44]. In regards to IL-8, 229 
its correlations with metabolic characteristics resembled those of MIG and an inverse correlation 230 
between IL-8 and z-BMI was also reported in a cohort of prepubertal children [42]. Although IL-8 231 
expression was demonstrated in adipose tissue, the correlation between MIG andIL-8 was 232 
independent of z-BMI in our study (data not shown). Thus, another source of MIG and IL-8 (like 233 
monocytes) could be suspected in prepubertal children with OB. Indeed, IFN-g promoted the 234 
secretion of IL-8 and MIG by monocytes in synergy with tumor necrosis factor (TNF)-a [45]. The 235 
positive correlation between RANTES and z-BMI is in line with T cell infiltration of adipose tissue 236 
as a consequence of fat mass expansion [38]. T cell infiltration is proposed as one of the earliest 237 
events in OB [46]. Thus, elevation of RANTES could be related to an adaptative response to OB in 238 
children, as RANTES exhibited antiapoptotic activities in adipose tissue macrophages [47]. 239 
Nonetheless, elevated RANTES levels were correlated with arterial stiffness, an early marker of 240 
endothelial dysfunction, in healthy prepubertal children [48]. Then, RANTES levels could mirror 241 
maladaptative responses in OB and it might be related with its cardiometabolic consequences. The 242 
cross-sectional design of our study did not allow us to draw conclusions on mechanisms and our 243 
hypothesis to explain the correlations observed are speculative. Nonetheless, few studies focused in 244 
the relationship between chemokines, NEFA and GFR in prepubertal children with OB. Moreover, 245 
children with severe OB represent a group of understudied individuals, especially before pubertal 246 
development. In the present cohort, severe OB was present in 33% of the children with z-BMI values 247 
ranging: 3.03e6.72. The evaluation of these patients by separate gave further support to the notion of 248 
declining GFR (and increasing uric acid levels) in children with OB as possible early events in the 249 
development of renal disease. Future studies will address if control of uric acid levels may help 250 
preserve renal function in childhood OB. On the other hand, the relatively low number of patients 251 
included, could be considered a shortcoming and raises the possibility to have missed relevant results. 252 
Among the strengths of the study there are two to be highlighted: a) the exclusion of patients with 253 
clinical or biochemical signs (hsCRP > 10 mg/l) of infectious or inflammatory conditions that 254 
minimized the possibility of bias in chemokine levels due to concomitant pathological processes and 255 
b) the use of sex and age-adjusted analysis to draw the main conclusions of the study. In conclusion, 256 
in prepubertal children with OW/OB serum levels of RANTES, IL-8 and MIG were not correlated 257 
with the GFR. Increasing z-BMI and worse metabolic profiles were associated with decreased rather 258 
than elevated GFR values. While RANTES was positively correlated with z-BMI, MIG showed an 259 
inverse correlation. Follow-up studies are needed to address the clinical implications of these 260 
findings. 261 
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